自己免疫疾患検査の世界市場2017-2021

◆英語タイトル:Global Autoimmune Disease Diagnostics Market 2017-2021
◆商品コード:IRTNTR10562
◆発行会社(調査会社):Technavio
◆発行日:2016年9月30日
◆ページ数:134
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥399,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,500 ⇒換算¥513,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥570,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。



当調査レポートでは、自己免疫疾患検査の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、自己免疫疾患検査の世界市場規模及び予測、製品別分析、需要先別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。
【レポートの概要】

About the Autoimmune Disease Diagnostics Market
Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by chronic inflammatory processes that activate the innate immune system and the production of antibodies that destroy host tissues. These inflammatory processes can be caused by genetic or environmental factors or infections.

Technavio’s analysts forecast the global autoimmune disease diagnostics market to grow at a CAGR of 6.39% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global autoimmune disease diagnostics market for 2017-2021. To calculate the market size, we use the revenue generated from the sales of various diagnostic tests for autoimmune diseases.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Autoimmune Disease Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Abbott Laboratories
• Beckman Coulter
• Bio-Rad Laboratories
• Inova Diagnostics
• Siemens Healthcare
• Thermo Fisher Scientific

[Other prominent vendors]
• AESKU Diagnostics
• Alere
• Autoimmune Technologies
• Bio-Diagnostics
• bioMérieux
• Diarect
• DiaSorin
• Erba Diagnostics
• Euro Diagnostica
• EUROIMMUN
• Exagen Diagnostics
• Gold Standard Diagnostics
• HUMAN Diagnostics
• ImmunArray
• KRONUS
• Menarini
• Myriad Genetics
• Omega Diagnostics
• ORGENTEC Diagnostika
• Protagen
• Qiagen
• Quest Diagnostics
• Roche Diagnostics
• Seramun Diagnostica
• SQI Diagnostics
• Tecan

[Market driver]
• Discovery of novel biomarkers
• For a full, detailed list, view our report

[Market challenge]
• Lack of skilled laboratory technicians
• For a full, detailed list, view our report

[Market trend]
• Shift from monoplex to multiplex testing
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights
• Autoimmune diseases

PART 05: Market landscape
• Market overview
• Five forces analysis

PART 06: Market segmentation by disease type
• Systemic autoimmune disease diagnostics
• Global systemic autoimmune disease market overview
• Localized autoimmune disease diagnostics
• Global localized autoimmune disease diagnostics market overview

PART 07: Market segmentation by product type
• Analyzers
• Global autoimmune diseases analyzers market overview
• Assay kits
• Global autoimmune disease assay kits market overview

PART 08: Market segmentation by test type
• ANA tests
• CRP
• Urinalysis test
• ESR
• CMP test
• Other

PART 09: Market segmentation by end-user
• Hospitals
• Diagnostic and research laboratories

PART 10: Geographical segmentation
• Autoimmune disease diagnostics market in Americas
• Autoimmune disease diagnostics market in EMEA
• Autoimmune disease diagnostics market in APAC

PART 11: Market drivers
• Discovery of novel biomarkers leading to improved autoimmune diagnosis
• Advancements in laboratory automation platforms
• Increasing M&A
• Product approvals and launches

PART 12: Impact of drivers

PART 13: Market challenges
• Limitation of autoimmune disease diagnostics
• Significant concerns over standardization and quality of immunoassay kits
• Lack of understanding on the basic etiology of several autoimmune diseases
• Shortage of skilled technicians for performing diagnostic assays

PART 14: Impact of drivers and challenges

PART 15: Market trends
• Focus on companion diagnostic tests
• Shift from monoplex to multiplex testing
• Collaboration between pharma and diagnostic companies
• Growing consumer shift toward direct-to-consumer testing

PART 16: Vendor landscape
• Competitive scenario
• Key news
• Vendors market share 2015

PART 17: Key vendor analysis
• Abbott Laboratories
• Beckman Coulter
• Bio-Rad Laboratories
• EUROIMMUN
• Inova Diagnostics
• Roche Diagnostics
• Siemens Healthcare
• Other prominent vendors

PART 18: Appendix
• List of abbreviations

PART 19: Explore Technavio

Exhibit 01: Product offerings
Exhibit 02: Etiology of autoimmune diseases
Exhibit 03: Signs and symptoms of autoimmune diseases
Exhibit 04: Average annual treatment cost of RA in US and Europe 2014 ($ billions)
Exhibit 05: Average annual treatment costs of multiple sclerosis across countries 2014 ($ billions)
Exhibit 06: Snapshot of global autoimmune disease diagnostics market 2016-2021
Exhibit 07: Global autoimmune disease diagnostics market snapshot
Exhibit 08: Key trends in global autoimmune disease diagnostics market
Exhibit 09: Global autoimmune disease diagnostics market 2016-2021 ($ millions)
Exhibit 10: Opportunity analysis in developed and emerging markets
Exhibit 11: Opportunity analysis of global autoimmune diagnostics market
Exhibit 12: Five forces analysis
Exhibit 13: Global autoimmune disease diagnostics market segmentation by disease type
Exhibit 14: Global systemic autoimmune disease diagnostics market 2016
Exhibit 15: Global localized autoimmune disease diagnostics market 2016
Exhibit 16: Global autoimmune disease diagnostics market segmentation by disease type 2016
Exhibit 17: Global autoimmune disease diagnostics market segmentation by disease type 2016
Exhibit 18: Antibodies for diagnosis of different systemic autoimmune diseases
Exhibit 19: Global systemic autoimmune disease diagnostics market 2016-2021 ($ millions)
Exhibit 20: Global RA diagnostics market 2016-2021 ($ millions)
Exhibit 21: Prevalence and incidence of SLE
Exhibit 22: Global SLE diagnostics market overview 2016-2021 ($ millions)
Exhibit 23: Global systemic autoimmune disease diagnostics market measurement parameters
Exhibit 24: Opportunity analysis of systemic autoimmune disease market
Exhibit 25: Antibodies used for diagnosis of different localized autoimmune diseases
Exhibit 26: Global localized autoimmune disease diagnostics market 2016-2021 ($ millions)
Exhibit 27: Opportunity analysis of localized autoimmune disease diagnostics market
Exhibit 28: Global type 1 diabetes diagnostics market 2016-2021 ($ millions)
Exhibit 29: Global autoimmune thyroiditis diagnostics market 2016-2021 ($ millions)
Exhibit 30: Global localized autoimmune disease diagnostics market measurement parameters
Exhibit 31: Global autoimmune disease diagnostics market segmentation by disease type 2016-2021 ($ millions)
Exhibit 32: Global autoimmune disease diagnostics market segmentation by disease type 2016-2021
Exhibit 33: Analysis of autoimmune disease diagnostics market segmentation by disease type
Exhibit 34: Global autoimmune disease diagnostics market segmentation by product type
Exhibit 35: Global autoimmune disease diagnostics market segmentation by product type 2016-2021
Exhibit 36: Global autoimmune disease diagnostics market segmentation by product type 2016
Exhibit 37: Global autoimmune disease diagnostics market segmentation by product type 2016
Exhibit 38: Some of the analyzers developed by vendors
Exhibit 39: Global autoimmune diseases analyzers market 2016-2021 ($ millions)
Exhibit 40: Opportunity analysis of autoimmune disease analyzers market
Exhibit 41: Some of the assays kits available in the market
Exhibit 42: Some of the key news related to assay kits
Exhibit 43: Global autoimmune diseases assay kits market 2016-2021 ($ millions)
Exhibit 44: Opportunity analysis for autoimmune disease assay kits
Exhibit 45: Analysis of autoimmune disease diagnostics market by product type
Exhibit 46: Global autoimmune disease diagnostics market by product type 2016-2021 ($ millions)
Exhibit 47: Global autoimmune disease diagnostics market by product type 2016-2021
Exhibit 48: Global autoimmune disease diagnostics market segmentation by test type
Exhibit 49: Global autoimmune disease diagnostics market segmentation by test type
Exhibit 50: Some of the examples of ANA tests
Exhibit 51: Global autoimmune disease diagnostics market segmentation by geography 2016-2021
Exhibit 52: Global autoimmune disease diagnostics market segmentation by geography 2016
Exhibit 53: Global autoimmune disease diagnostics market segmentation by geography 2016
Exhibit 54: Global autoimmune disease diagnostics market segmentation by geography 2016-2021 ($ millions)
Exhibit 55: Global autoimmune disease diagnostics market segmentation by geography 2016-2021
Exhibit 56: Americas: Market overview of autoimmune disease diagnostics
Exhibit 57: Comparison of US healthcare system: Before and after reforms
Exhibit 58: Autoimmune disease diagnostics market in Americas 2016-2021 ($ millions)
Exhibit 59: Autoimmune disease diagnostics market in EMEA 2016-2021 ($ millions)
Exhibit 60: EMEA: Market overview of autoimmune disease diagnostics
Exhibit 61: APAC: Market overview of autoimmune disease diagnostics
Exhibit 62: Autoimmune disease diagnostics market in APAC 2016-2021 ($ millions)
Exhibit 63: Key initiatives of vendors fueling the launch of novel biomarkers
Exhibit 64: Key highlights of laboratory automation
Exhibit 65: Some of the consolidations witnessed during 2015-2016
Exhibit 66: Impact of drivers
Exhibit 67: Force field analysis of global autoimmune disease diagnostics market
Exhibit 68: Impact of drivers and challenges
Exhibit 69: Impact of trends on global autoimmune disease diagnostics market
Exhibit 70: Vendors’ product development strategy for end-users
Exhibit 71: Competitive structure analysis of global autoimmune diagnostics market 2017-2021
Exhibit 72: Strategic success factors for companies in global autoimmune disease diagnostics market
Exhibit 73: Market penetration analysis of key vendors in autoimmune disease diagnostics 2015
Exhibit 74: Vendors’ market share breakdown 2015
Exhibit 75: Abbott Laboratories: Profile
Exhibit 76: Abbott Laboratories: Strength assessment
Exhibit 77: Abbott Laboratories: Strategy assessment
Exhibit 78: Abbott Laboratories: Opportunity assessment
Exhibit 79: Beckman Coulter: Key highlights
Exhibit 80: Beckman Coulter: Strength assessment
Exhibit 81: Beckman Coulter: Strategy assessment
Exhibit 82: Beckman Coulter: Opportunity assessment
Exhibit 83: Bio-Rad Laboratories: Key highlights
Exhibit 84: Bio-Rad Laboratories: Strength assessment
Exhibit 85: Bio-Rad Laboratories: Strategy assessment
Exhibit 86: Bio-Rad Laboratories: Opportunity assessment
Exhibit 87: EUROIMMUN: Profile
Exhibit 88: EUROIMMUN: Strength assessment
Exhibit 89: EUROIMMUN: Strategy assessment
Exhibit 90: EUROIMMUN: Opportunity assessment
Exhibit 91: Inova Diagnostics: Key highlights
Exhibit 92: Inova Diagnostics: Strength assessment
Exhibit 93: Inova Diagnostics: Strategy assessment
Exhibit 94: Inova Diagnostics: Opportunity assessment
Exhibit 95: Roche Diagnostics: Key highlights
Exhibit 96: Roche Diagnostics: Strength assessment
Exhibit 97: Roche Diagnostics: Strategy assessment
Exhibit 98: Roche Diagnostics: Opportunity assessment
Exhibit 99: Siemens Healthcare: Key highlights
Exhibit 100: Siemens Healthcare: Strength assessment
Exhibit 101: Siemens Healthcare: Strategy assessment
Exhibit 102: Siemens Healthcare: Opportunity assessment



【掲載企業】

Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, Inova Diagnostics, Siemens Healthcare, Thermo Fisher Scientific, AESKU Diagnostics, Alere, Autoimmune Technologies, Bio-Diagnostics, bioMérieux, Diarect, DiaSorin, Erba Diagnostics, Euro Diagnostica, EUROIMMUN, Exagen Diagnostics, Gold Standard Diagnostics, HUMAN Diagnostics, ImmunArray, KRONUS, Menarini, Myriad Genetics, Omega Diagnostics, ORGENTEC Diagnostika, Protagen, Qiagen, Quest Diagnostics, Roche Diagnostics, Seramun Diagnostica, SQI Diagnostics, Tecan.

【レポートのキーワード】

自己免疫疾患検査、自己免疫疾患検査、全身性自己免疫疾患、分析装置、アッセイキット、ANA検査、テスト、CRP、尿検査

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[自己免疫疾患検査の世界市場2017-2021]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。
※当サイトでは2016年12月05日現在 219,162 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆